NEXGEL, Inc. (NASDAQ:NXGL – Get Free Report) was the target of a significant increase in short interest in the month of January. As of January 31st, there was short interest totalling 131,100 shares, an increase of 14.7% from the January 15th total of 114,300 shares. Currently, 2.5% of the company’s shares are sold short. Based on an average daily volume of 128,900 shares, the short-interest ratio is presently 1.0 days.
NEXGEL Stock Up 4.7 %
NASDAQ:NXGL opened at $3.53 on Monday. The company has a quick ratio of 0.93, a current ratio of 1.51 and a debt-to-equity ratio of 0.19. The business has a 50 day simple moving average of $3.84 and a 200-day simple moving average of $3.22. NEXGEL has a 1 year low of $1.84 and a 1 year high of $5.10.
Institutional Trading of NEXGEL
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Renaissance Technologies LLC increased its position in NEXGEL by 456.4% during the fourth quarter. Renaissance Technologies LLC now owns 158,331 shares of the company’s stock valued at $706,000 after acquiring an additional 129,876 shares during the last quarter. Northeast Financial Group Inc. boosted its stake in shares of NEXGEL by 168.8% during the 3rd quarter. Northeast Financial Group Inc. now owns 31,848 shares of the company’s stock worth $82,000 after purchasing an additional 20,000 shares during the period. Two Sigma Securities LLC bought a new position in NEXGEL during the 4th quarter valued at about $54,000. IFP Advisors Inc purchased a new stake in NEXGEL in the 4th quarter worth about $49,000. Finally, Virtu Financial LLC bought a new stake in NEXGEL in the fourth quarter worth about $48,000. Hedge funds and other institutional investors own 2.21% of the company’s stock.
About NEXGEL
NEXGEL, Inc manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc and changed its name to NEXGEL, Inc in November 2019.
Featured Articles
- Five stocks we like better than NEXGEL
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Kyndryl Soars on AI, Cybersecurity Growth—What’s Next?
- What Makes a Stock a Good Dividend Stock?
- Conflicting Signals: Tempus AI’s Stock Market Rally
- Industrial Products Stocks Investing
- Novo Nordisk Shares Near New 52-Week Low: Analysts See Big Upside
Receive News & Ratings for NEXGEL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NEXGEL and related companies with MarketBeat.com's FREE daily email newsletter.
